Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?

go back to reference American Heart Association: Heart disease and stroke statistics – 2005 update. [http://www.americanheart.org/downloadable/heart/1105390918119HDSStats2005Update.pdf] American Heart Association: Heart disease and stroke statistics – 2005 update. [http://​www.​americanheart.​org/​downloadable/​heart/​1105390918119HDS​Stats2005Update.​pdf]

go back to reference Rich MW: Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997, 45: 968-74.CrossRefPubMed Rich MW: Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997, 45: 968-74.CrossRefPubMed

go back to reference Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J: Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997, 157: 99-104. 10.1001/archinte.157.1.99.CrossRefPubMed Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J: Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997, 157: 99-104. 10.1001/archinte.157.1.99.CrossRefPubMed

go back to reference Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005, 112: e154-235. 10.1161/CIRCULATIONAHA.105.167586.CrossRefPubMed Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005, 112: e154-235. 10.1161/CIRCULATIONAHA.105.167586.CrossRefPubMed

go back to reference Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K, ESC Committe for Practice Guideline (CPG): Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005, 26: 384-416. 10.1093/eurheartj/ehi044.CrossRefPubMed Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K, ESC Committe for Practice Guideline (CPG): Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005, 26: 384-416. 10.1093/eurheartj/ehi044.CrossRefPubMed

go back to reference Scios Inc: Prescribing information, revised 4/29/05. [http://www.natrecor.com/pdf/natrecor_pi.pdf] Scios Inc: Prescribing information, revised 4/29/05. [http://​www.​natrecor.​com/​pdf/​natrecor_​pi.​pdf]

go back to reference Michaels AD, Klein A, Madden JA, Chatterjee K: Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation. 2003, 107: 2697-701. 10.1161/01.CIR.0000070547.88378.EA.CrossRefPubMed Michaels AD, Klein A, Madden JA, Chatterjee K: Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation. 2003, 107: 2697-701. 10.1161/01.CIR.0000070547.88378.EA.CrossRefPubMed

go back to reference Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group: In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005, 46: 57-64. 10.1016/j.jacc.2005.03.051.CrossRefPubMed Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group: In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005, 46: 57-64. 10.1016/j.jacc.2005.03.051.CrossRefPubMed

go back to reference Costanzo MR, Heywood JT, Emerman CL, Abraham WT, Yancy CW, Berkowitz RL, Cheng ML: Evaluation of in-hospital mortality in patients treated for acute heart failure within the first 24 hours with nesiritide vs. other vasoactive or inotropic agents [abstract]. Circulation. 2003, 108 (suppl IV): IV-695. Costanzo MR, Heywood JT, Emerman CL, Abraham WT, Yancy CW, Berkowitz RL, Cheng ML: Evaluation of in-hospital mortality in patients treated for acute heart failure within the first 24 hours with nesiritide vs. other vasoactive or inotropic agents [abstract]. Circulation. 2003, 108 (suppl IV): IV-695.

go back to reference Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson KD: Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005, 293: 1900-5. 10.1001/jama.293.15.1900.CrossRefPubMed Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson KD: Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005, 293: 1900-5. 10.1001/jama.293.15.1900.CrossRefPubMed

go back to reference Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005, 111: 1487-91. 10.1161/01.CIR.0000159340.93220.E4.CrossRefPubMed Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005, 111: 1487-91. 10.1161/01.CIR.0000159340.93220.E4.CrossRefPubMed

go back to reference Saul S: Heart clinic may end or curtail use of a drug. The New York Times, [http://www.nytimes.com/2005/05/04/health/04heart.html?ex=1188532800%26en=016cf22aa5f08596%26ei=5070] Saul S: Heart clinic may end or curtail use of a drug. The New York Times, [http://​www.​nytimes.​com/​2005/​05/​04/​health/​04heart.​html?​ex=​1188532800%26en=​016cf22aa5f08596​%26ei=​5070]

go back to reference Scios Inc: Panel of cardiology experts recommendations toScios regarding Natrecor. [http://www.sciosinc.com/scios/pr_1118721302] Scios Inc: Panel of cardiology experts recommendations toScios regarding Natrecor. [http://​www.​sciosinc.​com/​scios/​pr_​1118721302]

go back to reference Battleman DS, Callahan M, Thaler HT: Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med. 2002, 162: 682-8. 10.1001/archinte.162.6.682.CrossRefPubMed Battleman DS, Callahan M, Thaler HT: Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med. 2002, 162: 682-8. 10.1001/archinte.162.6.682.CrossRefPubMed

go back to reference Hauck LD, Adler LM, Mulla ZD: Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia. Ann Epidemiol. 2004, 14: 669-75. 10.1016/j.annepidem.2004.01.003.CrossRefPubMed Hauck LD, Adler LM, Mulla ZD: Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia. Ann Epidemiol. 2004, 14: 669-75. 10.1016/j.annepidem.2004.01.003.CrossRefPubMed

go back to reference 3M Health Information Systems: All patient refined diagnosis related groups (APR-DRGs) – methodology overview. 2003, Document GRP-041, Version 20.0: 88 pages 3M Health Information Systems: All patient refined diagnosis related groups (APR-DRGs) – methodology overview. 2003, Document GRP-041, Version 20.0: 88 pages

go back to reference Cole SR: Analysis of complex survey data using SAS. Comput Methods Programs Biomed. 2001, 64: 65-9. 10.1016/S0169-2607(00)00088-2.CrossRefPubMed Cole SR: Analysis of complex survey data using SAS. Comput Methods Programs Biomed. 2001, 64: 65-9. 10.1016/S0169-2607(00)00088-2.CrossRefPubMed

go back to reference Hosmer DW, Lemeshow S: Applied Logistic Regression. 2000, New York: John Wiley and Sons, 313-2CrossRef Hosmer DW, Lemeshow S: Applied Logistic Regression. 2000, New York: John Wiley and Sons, 313-2CrossRef

go back to reference Saul S: U.S. looking at marketing by Johnson & Johnson. The New York Times, [http://www.nytimes.com/2005/07/21/business/21natrecor.html?ei=5090%26en=02f01378f6bfae24%26ex=1279598400%26partner=rssuserland%26emc=rss%26pagewanted=all] Saul S: U.S. looking at marketing by Johnson & Johnson. The New York Times, [http://​www.​nytimes.​com/​2005/​07/​21/​business/​21natrecor.​html?​ei=​5090%26en=​02f01378f6bfae24​%26ex=​1279598400%26partner=​rssuserland%26emc=​rss%26pagewanted=​all]

go back to reference Carroll R, Mulla ZD, Hauck LD, Westbrook A: Nesiritide increases the odds of mortality among patients hospitalized for congestive heart failure [abstract]. Am J Epidemiol. 2006, 163 (Suppl): S1-10.1093/aje/kwj215. Carroll R, Mulla ZD, Hauck LD, Westbrook A: Nesiritide increases the odds of mortality among patients hospitalized for congestive heart failure [abstract]. Am J Epidemiol. 2006, 163 (Suppl): S1-10.1093/aje/kwj215.

go back to reference Carroll RJ, Mulla ZD, Hauck LD, Westbrook A: Mortality associated with nesiritide. Am Heart J. 2007, 153: e43-10.1016/j.ahj.2007.03.039.CrossRefPubMed Carroll RJ, Mulla ZD, Hauck LD, Westbrook A: Mortality associated with nesiritide. Am Heart J. 2007, 153: e43-10.1016/j.ahj.2007.03.039.CrossRefPubMed

go back to reference Aaronson KD, Sackner-Bernstein J: Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA. 2006, 296: 1465-6. 10.1001/jama.296.12.1465.CrossRefPubMed Aaronson KD, Sackner-Bernstein J: Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA. 2006, 296: 1465-6. 10.1001/jama.296.12.1465.CrossRefPubMed

go back to reference Fonarow GC, Corday E, ADHERE Scientific Advisory Committee: Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev. 2004, 9: 179-85. 10.1007/s10741-005-6127-6.CrossRefPubMed Fonarow GC, Corday E, ADHERE Scientific Advisory Committee: Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev. 2004, 9: 179-85. 10.1007/s10741-005-6127-6.CrossRefPubMed

go back to reference Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF): Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure; a randomized controlled trial. JAMA. 2002, 287: 1531-40. 10.1001/jama.287.12.1531. Erratum in JAMA 2002;288:577 Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF): Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure; a randomized controlled trial. JAMA. 2002, 287: 1531-40. 10.1001/jama.287.12.1531. Erratum in JAMA 2002;288:577

go back to reference Topol EJ: Nesiritide – not verified. N Engl J Med. 2005, 353: 113-6. 10.1056/NEJMp058139.CrossRefPubMed Topol EJ: Nesiritide – not verified. N Engl J Med. 2005, 353: 113-6. 10.1056/NEJMp058139.CrossRefPubMed